适度至严重的季节性过敏性鼻炎的Stapokibart:一个随机的第三阶段试验
Yuan Zhang1,2,3,4,5, Jingyun Li2,3,4,5, Menglin Wang2,3,4,5
1The Department of Allergy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
斯泰波基巴特显著改善了季节性过敏性鼻炎 (SAR) 患者的鼻腔和眼部症状. 这种单克隆抗体疗法减少了2型炎症,为严重的SAR提供了新的治疗选择.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和临床免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 季节性过敏性鼻炎 (SAR) 给社会经济带来了重大负担,特别是对于那些严重,反复出现症状且标准治疗不够有效的人来说.
- 2型炎症在SAR病原发生过程中起着关键作用.
- 准介素-4受体α子单元提供了一个潜在的治疗策略.
研究的目的:
- 评估斯塔波基巴特作为中度至重度SAR的成年人补充治疗的疗效和安全性.
- 评估Stapokibart对鼻子和眼部症状的影响,以及SAR患者的生活质量.
主要方法:
- 一项3期,多中心,随机,双盲,安慰剂对照试验,涉及108名中度至重度SAR和血中异氨基细胞升高的患者.
- 参与者接受了Stapokibart (600mg的加载剂量每2周增加到300mg) 或安慰剂,用皮下注射4周.
- 主要终点:两周内每日反射总鼻腔症状评分 (rTNSS) 的基线平均变化. 二级终点包括4周的症状得分和生活质量指标.
主要成果:
- 与安慰剂相比,Stapokibart在2周 (LS平均差异: -1.3;P=0.0008) 和4周 (LS平均差异: -1.7;P=0.0002) 的每日rTNSS的平均变化比基线有统计学显著的改善.
- 在多重测试的二次终点,包括眼部症状和生活质量方面,也观察到显著的改善.
- 治疗出现的不良事件在斯塔波基巴特和安慰剂组之间是可比的.
结论:
- 在中度至重度SAR患者中,季节性施用斯塔波基巴特有效改善了鼻腔和眼部症状.
- 该研究表明,斯塔波基巴特的疗效与减少2型炎症有关.
- 斯泰波基巴特 (Stapokibart) 是一种有前途的治疗选择,用于治疗严重的SAR,改善患者的生活质量.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-III: Symptoms and Complications
Classification of Asthma
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
